These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 30516854)

  • 41. Precise ratiometric loading of PTX and DOX based on redox-sensitive mixed micelles for cancer therapy.
    Zhao D; Wu J; Li C; Zhang H; Li Z; Luan Y
    Colloids Surf B Biointerfaces; 2017 Jul; 155():51-60. PubMed ID: 28407531
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Systematic evaluation of multifunctional paclitaxel-loaded polymeric mixed micelles as a potential anticancer remedy to overcome multidrug resistance.
    Zhang J; Zhao X; Chen Q; Yin X; Xin X; Li K; Qiao M; Hu H; Chen D; Zhao X
    Acta Biomater; 2017 Mar; 50():381-395. PubMed ID: 27956367
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The antitumor efficacy of functional paclitaxel nanomicelles in treating resistant breast cancers by oral delivery.
    Yao HJ; Ju RJ; Wang XX; Zhang Y; Li RJ; Yu Y; Zhang L; Lu WL
    Biomaterials; 2011 Apr; 32(12):3285-302. PubMed ID: 21306774
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Actively targeting D-α-tocopheryl polyethylene glycol 1000 succinate-poly(lactic acid) nanoparticles as vesicles for chemo-photodynamic combination therapy of doxorubicin-resistant breast cancer.
    Jiang D; Gao X; Kang T; Feng X; Yao J; Yang M; Jing Y; Zhu Q; Feng J; Chen J
    Nanoscale; 2016 Feb; 8(5):3100-18. PubMed ID: 26785758
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dual pH-sensitive micelles with charge-switch for controlling cellular uptake and drug release to treat metastatic breast cancer.
    Tang S; Meng Q; Sun H; Su J; Yin Q; Zhang Z; Yu H; Chen L; Gu W; Li Y
    Biomaterials; 2017 Jan; 114():44-53. PubMed ID: 27842234
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transferrin receptor-targeted redox/pH-sensitive podophyllotoxin prodrug micelles for multidrug-resistant breast cancer therapy.
    Li Y; Chen M; Yao B; Lu X; Zhang X; He P; Vasilatos SN; Ren X; Bian W; Yao C
    J Mater Chem B; 2019 Oct; 7(38):5814-5824. PubMed ID: 31495855
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of breast cancer metastasis by paclitaxel-loaded pH responsive poly(β-amino ester) copolymer micelles.
    Chen Y; Yue Q; De G; Wang J; Li Z; Xiao S; Yu H; Ma H; Sui F; Zhao Q
    Nanomedicine (Lond); 2017 Jan; 12(2):147-164. PubMed ID: 27854565
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dual-targeted nano-in-nano albumin carriers enhance the efficacy of combined chemo/herbal therapy of lung cancer.
    Elgohary MM; Helmy MW; Mortada SM; Elzoghby AO
    Nanomedicine (Lond); 2018 Sep; 13(17):2221-2224. PubMed ID: 30265215
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dual pH-responsive multifunctional nanoparticles for targeted treatment of breast cancer by combining immunotherapy and chemotherapy.
    Liu Y; Qiao L; Zhang S; Wan G; Chen B; Zhou P; Zhang N; Wang Y
    Acta Biomater; 2018 Jan; 66():310-324. PubMed ID: 29129789
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dual-Targeted Delivery of Nanoparticles Encapsulating Paclitaxel and Everolimus: a Novel Strategy to Overcome Breast Cancer Receptor Heterogeneity.
    Houdaihed L; Evans JC; Allen C
    Pharm Res; 2020 Jan; 37(3):39. PubMed ID: 31965330
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reduction-Triggered Paclitaxel Release Nano-Hybrid System Based on Core-Crosslinked Polymer Dots with a pH-Responsive Shell-Cleavable Colorimetric Biosensor.
    Kim SG; Ryplida B; Phuong PTM; Won HJ; Lee G; Bhang SH; Park SY
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31661903
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tannic acid-inspired paclitaxel nanoparticles for enhanced anticancer effects in breast cancer cells.
    Chowdhury P; Nagesh PKB; Hatami E; Wagh S; Dan N; Tripathi MK; Khan S; Hafeez BB; Meibohm B; Chauhan SC; Jaggi M; Yallapu MM
    J Colloid Interface Sci; 2019 Feb; 535():133-148. PubMed ID: 30292104
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Biodegradable, Hydrogen Peroxide, and Glutathione Dual Responsive Nanoparticles for Potential Programmable Paclitaxel Release.
    Chen D; Zhang G; Li R; Guan M; Wang X; Zou T; Zhang Y; Wang C; Shu C; Hong H; Wan LJ
    J Am Chem Soc; 2018 Jun; 140(24):7373-7376. PubMed ID: 29799737
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Targeted Nanostructured Lipid Carriers for Delivery of Paclitaxel to Cancer Cells: Preparation, Characterization, and Cell Toxicity.
    Rezazadeh M; Emami J; Hassanzadeh F; Sadeghi H; Rostami M; Mohammadkhani H
    Curr Drug Deliv; 2017; 14(8):1189-1200. PubMed ID: 28472908
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Micelle System Based on Molecular Economy Principle for Overcoming Multidrug Resistance and Inhibiting Metastasis.
    Qi Y; Qin X; Yang C; Wu T; Qiao Q; Song Q; Zhang Z
    Mol Pharm; 2018 Mar; 15(3):1005-1016. PubMed ID: 29397749
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tripalmitin nanoparticle formulations significantly enhance paclitaxel antitumor activity against breast and lung cancer cells in vitro.
    Leiva MC; Ortiz R; Contreras-Cáceres R; Perazzoli G; Mayevych I; López-Romero JM; Sarabia F; Baeyens JM; Melguizo C; Prados J
    Sci Rep; 2017 Oct; 7(1):13506. PubMed ID: 29044153
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prodrug-based nano-drug delivery system for co-encapsulate paclitaxel and carboplatin for lung cancer treatment.
    Zhang W; Li C; Shen C; Liu Y; Zhao X; Liu Y; Zou D; Gao Z; Yue C
    Drug Deliv; 2016 Sep; 23(7):2575-2580. PubMed ID: 26056720
    [TBL] [Abstract][Full Text] [Related]  

  • 58.
    Gibbens-Bandala B; Morales-Avila E; Ferro-Flores G; Santos-Cuevas C; Meléndez-Alafort L; Trujillo-Nolasco M; Ocampo-García B
    Mater Sci Eng C Mater Biol Appl; 2019 Dec; 105():110043. PubMed ID: 31546458
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-circulating self-assembled cholesteryl albumin nanoparticles enhance tumor accumulation of hydrophobic anticancer drug.
    Battogtokh G; Kang JH; Ko YT
    Eur J Pharm Biopharm; 2015 Oct; 96():96-105. PubMed ID: 26212785
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Low-density lipoprotein-coupled micelles with reduction and pH dual sensitivity for intelligent co-delivery of paclitaxel and siRNA to breast tumor.
    Zhu WJ; Yang SD; Qu CX; Zhu QL; Chen WL; Li F; Yuan ZQ; Liu Y; You BG; Zhang XN
    Int J Nanomedicine; 2017; 12():3375-3393. PubMed ID: 28490877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.